James Fang, M.D., to lead cardiovascular medicine at University of Utah

Published on:

Newswise — (SALT LAKE CITY)— James Chen-tson Fang, M.D., has been named chief of cardiovascular medicine at the University of Utah School of Medicine and director of the cardiovascular service line at University of Utah Health Care.

Fang, who specializes in treatment of patients with heart failure, most recently held the Spitz Master Clinician Chair at Case Western Reserve University School of Medicine in Cleveland, where he was a professor of medicine and associate chief of clinical affairs for cardiovascular medicine. He is a highly regarded clinician, teacher, mentor and researcher.

“Dr. Fang is a distinguished clinician/educator and investigator who represents the pinnacle of academic medicine and personal integrity,” says John R. Hoidal, M.D., chairman of the University of Utah Department of Internal Medicine.

Fang’s role at the University of Utah will include leading efforts to ensure the institution is recognized as a premier clinical, educational, and research institution for cardiovascular disease. He will continue to develop highly skilled multidisciplinary teams that provide comprehensive, personalized and cost-effective care, and oversee integration of research and clinical care programs.

While at Case Western Reserve, Fang served as Medical Director of the Heart Failure, Transplant, and Circulatory Assist Program and chief medical officer for the Harrington Heart and Vascular Institute.

“We are thrilled to welcome Dr. Fang to the University of Utah where we know his expertise will bring an immediate impact to our health system,” says David Entwistle, CEO of University of Utah Hospitals and Clinics.

Fang graduated from the Duke University School of Medicine in 1988, and went on to complete internships and residencies at Johns Hopkins Hospital in Baltimore as well as a cardiovascular fellowship at Brigham and Women’s Hospital in Boston. The author of multiple books, Fang has taught at Case Western Reserve, Johns Hopkins, and at the Harvard University School of Medicine.

Related Content

American Heart Association announces late-breaking research for Scientific Sessions 2024
Impella ECP confirmed to be safe for high-risk PCI—is FDA approval next?
New Category I CPT codes announced for treating heart failure with implantable Barostim device
Cardiologists make case for increasing use of device-based therapies for heart failure
Obesity-related deaths on the rise in US—but there is good news for cardiologists
Johnson & Johnson completes V-Wave acquisition

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup